110
Participants
Start Date
June 16, 2025
Primary Completion Date
September 1, 2025
Study Completion Date
December 1, 2025
Continuous vital sign monitoring
Continuous monitoring of vital signs performed using up to three CE- and FDA approved devices measuring heart rate, respiratory rate, systolic- and diastolic blood pressure, and SpO2. Data is transmitted to a CE-approved smartphone application that generates alerts in response to deviations based on predefined thresholds for duration and severity.
Bispebjerg Hospital, Copenhagen
Bispebjerg Hospital
OTHER